Self-testing, oral medication and discounted screening offer different ways to make healthcare more accessible. These innovations address where testing happens, how treatment is taken and what a screening service costs.
Laboratorios Richmond has introduced OraQuick, an ANMAT-authorised oral-fluid HIV self-test for home use in Argentina. The test provides a reading in 20–40 minutes and is intended for sale through pharmacies and online channels, at an estimated price of ARS 27,500. A reactive result requires confirmatory testing through a healthcare service.
Novo Nordisk has received Anvisa approval in Brazil for a once-daily tablet version of Wegovy for chronic weight management in eligible adults with obesity or overweight. The oral formulation provides an alternative to injectable treatment, with use guided by a healthcare professional.
Novi Beograd has partnered with GenePlanet to offer pregnant residents vouchers for a 40% discount on its Lumipeek non-invasive prenatal test. The screening uses a blood sample to assess the risk of certain genetic conditions. The partnership makes the service available at a reduced price for eligible residents.
